Search Within

Lisa Rebecca Modelevsky

Formats
  1. Journal Article (6)
  2. Meeting Abstract (5)
  3. Research Letter (1)
Groups
  1. Clinical Pharmacy Specialists (12)
  2. Biostatistics Service (3)
  3. Epidemiology and Biostatistics (3)
  4. Population Sciences Research Program (3)
  5. Advanced Practice Providers (1)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1)

More Groups

People
  1. Samantha Reiss (10)
  2. Prakirthi Yerram (7)
  3. Christian Grommes (6)
  4. Anne Reiner (4)
  5. Thomas Kaley (4)
  6. Katherine Panageas (3)

More People

Years
  1. 2024 (1)
  2. 2023 (1)
  3. 2022 (2)
  4. 2021 (1)
  5. 2019 (3)
  6. 2018 (1)

More Years

Publications
  1. Neuro-Oncology (3)
  2. Leukemia and Lymphoma (2)
  3. Annals of Lymphoma (1)
  4. Blood (1)
  5. CNS Oncology (1)
  6. Journal for ImmunoTherapy of Cancer (1)

More Publications

Publishers
  1. Oxford University Press (3)
  2. Taylor & Francis Group (2)
  3. AME Publishing Company (1)
  4. American Society of Clinical Oncology (1)
  5. American Society of Hematology (1)
  6. Biomed Central Ltd (1)

More Publishers

Results (12)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Treatment of methotrexate-refractory primary central nervous system lymphoma (PCNSL) at Memorial Sloan Kettering Cancer Center
    Research Letter

    Cherian, S.; Modelevsky, L.; Reiner, A. S.; Grommes, C.
    Leukemia and Lymphoma (2024)

    Fulltext@MSK | Save
  • Is more better? Increased doses of high dose methotrexate and addition of rituximab is associated with improved outcomes in a large primary CNS lymphoma cohort
    Journal Article

    Yerram, P.; Reiss, S. N.; Modelevsky, L.; Schaff, L.; Reiner, A. S.; Panageas, K. S.; Grommes, C.
    Annals of Lymphoma (2023)

    Fulltext@MSK | Save
  • A phase Ia/Ib study of intrathecal deferoxamine in patients with leptomeningeal metastases
    Meeting Abstract

    Wilcox, J.; Modelevsky, L. R.; Thomas, T.; Cremers, S.; Young, R. J.; Reiner, A. S.; Panageas, K.; Yu, H. A.; Boire, A. A.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Rituximab, methotrexate, carmustine, etoposide, and prednisone (RMBVP) for the treatment of relapsed/refractory primary central nervous system lymphoma: A retrospective single-center study
    Journal Article

    Reiss, S. N.; Yerram, P.; Modelevsky, L.; Grommes, C.
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save
  • Outpatient clinical pharmacy practice in the face of COVID-19 at a cancer center in New York City
    Journal Article

    Yerram, P.; Thackray, J.; Modelevsky, L. R.; Land, J. D.; Reiss, S. N.; Spatz, K. H.; Levoir, A. C.; Pak, T. K.; Dao, P. H.; Buege, M. J.; more...
    Journal of Oncology Pharmacy Practice (2021)

    Fulltext@MSK | Save
  • Increased number of high dose methotrexate cycles and the addition of rituximab is associated with better outcomes in a large primary CNSL cohort
    Meeting Abstract

    Yerram, P.; Reiss, S. N.; Modelevsky, L.; Schaff, L.; Reiner, A.; Panageas, K.; Grommes, C.
    Blood (2019)

    Fulltext@MSK | Save
  • Rituximab, methotrexate, BCNU, etoposide, and prednisone (RMBVP) for the treatment of relapsed/recurrent primary central nervous system lymphoma: A retrospective single center study
    Meeting Abstract

    Reiss, S.; Yerram, P.; Modelevsky, L.; Grommes, C.
    Neuro-Oncology (2019)

    Fulltext@MSK | Save
  • Evaluation of toxicity of carmustine with or without bevacizumab in patients with recurrent or progressive high grade gliomas
    Journal Article

    Yerram, P.; Reiss, S. N.; Modelevsky, L.; Gavrilovic, I. T.; Kaley, T.
    Journal of Neuro-Oncology (2019)

    Fulltext@MSK | Save
  • Rapid infusion rituximab is well tolerated in patients with primary CNS lymphoma
    Journal Article

    Modelevsky, L.; Tizon, R.; Reiss, S. N.; Smith, M.; Garonce, R.; Kaley, T.
    CNS Oncology (2018)

    Fulltext@MSK | Save
  • Toxicity of single agent carmustine versus carmustine plus bevacizumab in patients with recurrent or progressive high grade gliomas
    Meeting Abstract

    Yerram, P.; Reiss, S.; Modelevsky, L.; Gavrilovic, I.; Kaley, T.
    Neuro-Oncology (2017)

    Fulltext@MSK | Save